Top Markets
#1 Black Phoenix Black Phoenix +21,336.93%
#2 Nesa Nesa +789.76%
#3 Cortex Cortex +67.88%
#4 Kinesis Silver Kinesis Silver +55.45%
#5 QuantixAI QuantixAI +23.76%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +18.71%
#8 Alchemist AI Alchemist AI +14.59%
#9 Pons Pons +14.37%
#10 PondCoin PondCoin +13.60%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Rank in Stocks #3217
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Share Price
$44.42
Last synced: 2026-08-25
Market Cap
$5.90B
Change (1 day)
2.66%
Change (1 year)
344.66%
Country
US
Trade Definium Therapeutics, Inc. (DFTX)

Category

Healthcare
Stock price history for Definium Therapeutics, Inc. (DFTX)
Highest end of day price: $44.49 on 2026-08-01

Lowest end of day price: $4.81 on 2016-11-01
Stock price history of Definium Therapeutics, Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 65.08%
2025 74.98%
2024 107.98%
2023 34.70%
2022 -89.90%
2021 -40.72%
2020 7,946.66%
2019 -31.09%
2018 -81.58%
2017 -37.50%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $769.15 6.90%
CH